BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai J, Deng H, Luo L, You L, Liao H, Zheng Y. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma. Aging (Albany NY) 2020;13:2073-88. [PMID: 33323549 DOI: 10.18632/aging.202205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Liu Y, Xu Z, Chen Q. miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma. IJGM 2022;Volume 15:3433-45. [DOI: 10.2147/ijgm.s352120] [Reference Citation Analysis]
2 Chen J, Liao Y, Fan X. Prognostic and clinicopathological value of BUB1B expression in patients with lung adenocarcinoma: a meta-analysis. Expert Rev Anticancer Ther 2021;21:795-803. [PMID: 33764838 DOI: 10.1080/14737140.2021.1908132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu T, Dai T, Zeng P, Song Q, He K, Hu Z, Li Y, Li Z. Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma. Transl Cancer Res 2021;10:3811-28. [PMID: 35116680 DOI: 10.21037/tcr-21-1316] [Reference Citation Analysis]